No Data
Risks To Shareholder Returns Are Elevated At These Prices For APT Medical Inc. (SHSE:688617)
APT Medical Gets Registration Certificate for Vena Cava Filter System
APT Medical Gets Medical Device Registration for Medical Catheter Sensor
APT Medical Inc. (688617.SH): The disposable magnetic positioning pressure monitoring radiofrequency ablation catheter has obtained the medical instruments registration certificate.
On February 26, Glonghui reported that APT Medical Inc. (688617.SH) announced that its wholly-owned subsidiary Hunan APT Medical Instruments Co., Ltd. has obtained a medical instruments registration certificate for the product name: disposable magnetic positioning pressure monitoring radiofrequency ablation catheter. The acquisition of this medical instruments registration certificate is beneficial for enriching the company's product variety, expanding the company's product layout in the field of electrophysiology, continuously meeting diverse clinical needs, and further enhancing the company's core competitiveness.
Research Reports Mining丨Founder Securities: APT Medical Inc.'s overall performance in Q4 remains stable, maintaining a 'recommended' rating.
The research report from Founder Securities indicates that APT Medical Inc. (688617.SH) has stable overall growth in its main business, with domestic growth currently under pressure. The launch of the PFA is expected to drive performance back to high growth. In the fourth quarter, the company achieved over 20% year-on-year growth in both revenue and net income excluding non-recurring items, maintaining consistent performance. On December 16, 2024, the disposable cardiac pulsed electric field ablation catheter (PFA) was approved by the NMPA, and this technology is rapidly penetrating the atrial fibrillation market. It is expected to drive surgical upgrades through better clinical outcomes, contributing new acceleration to the company's performance. In 2024, the company will continue to operate in the overseas market with its own brand.
Huitai Healthcare: 2024 Annual Results Express Announcement
If EPS Growth Is Important To You, APT Medical (SHSE:688617) Presents An Opportunity
